The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Bacteriocins as Potential Anticancer Agents
Open accessAbstract
Cancer remains one of the leading causes of deaths worldwide, despite advances in its treatment and detection. The conventional chemotherapeutic agents used for the treatment of cancer have non-specific toxicity toward normal body cells that cause various side effects. Secondly, cancer cells are known to develop chemotherapy resistance in due course of treatment. Thus, the demand for novel anti-cancer agents is increasing day by day. Some of the experimental studies have reported the therapeutic potential of bacteriocins against various types of cancer cell lines. Bacteriocins are ribosomally-synthesized cationic peptides secreted by almost all groups of bacteria. Some bacteriocins have shown selective cytotoxicity toward cancer cells as compared to normal cells. This makes them promising candidates for further investigation and clinical trials. In this review article, we present the overview of the various cancer cell-specific cytotoxic bacteriocins, their mode of action and efficacies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Bacteriocins of gram-positive bacteria
Jack, R. W., Tagg, J. R., & Ray, B. (1995) · Microbiological Reviews · doi:10.1128/mr.59.2.171-200.1995 · Cited by 2,711
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Bacteriocins: Developing innate immunity for food
Cotter, P. D., Hill, C., & Ross, R. P. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1273 · Cited by 2,380
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
Rembacken, B., Snelling, A., Hawkey, P., Chalmers, D., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,101
Wiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O. P., Bierbaum, G., de Kruijff, B., & Sahl, H.-G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006770200 · Cited by 790
The Continuing Story of Class IIa Bacteriocins
Drider, D., Fimland, G., Héchard, Y., McMullen, L. M., & Prévost, H. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-05 · Cited by 749
From antimicrobial to anticancer peptides. A review
Gaspar, D., Veiga, A. S., & Castanho, M. A. R. B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00294 · Cited by 749
Bacteriocins: Biological tools for bio-preservation and shelf-life extension
Deegan, L. H., Cotter, P. D., Hill, C., & Ross, P. (2006) · International Dairy Journal · doi:10.1016/j.idairyj.2005.10.026 · Cited by 682
Utsugi, T., Schroit, A. J., Connor, J., Bucana, C. D., & Fidler, I. J. (1991) · PubMed · Cited by 594
The pyocins of Pseudomonas aeruginosa
Michel-Briand, Y., & Baysse, C. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01422-0 · Cited by 560
Cationic amphiphilic peptides with cancer-selective toxicity
Schweizer, F. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.043 · Cited by 517
Sahl, H.-G., & Bierbaum, G. (1998) · Annual Review of Microbiology · doi:10.1146/annurev.micro.52.1.41 · Cited by 476
Bacteriocins Produced by Lactic Acid Bacteria a Review Article
Zacharof, M. P., & Lovitt, R. W. (2012) · APCBEE Procedia · doi:10.1016/j.apcbee.2012.06.010 · Cited by 431
Ruhr, E., & Sahl, H. G. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.5.841 · Cited by 375
Liu, W., & Hansen, J. N. (1990) · Applied and Environmental Microbiology · doi:10.1128/aem.56.8.2551-2558.1990 · Cited by 374
Pediocins: The bacteriocins of Pediococci. Sources, production, properties and applications
Papagianni, M., & Anastasiadou, S. (2009) · Microbial Cell Factories · doi:10.1186/1475-2859-8-3 · Cited by 342
Riedl, S., Rinner, B., Asslaber, M., Schaider, H., Walzer, S., Novak, A., Lohner, K., & Zweytick, D. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.07.026 · Cited by 331
Diep, D. B., Håvarstein, L. S., & Nes, I. F. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.15.4472-4483.1996 · Cited by 328
Resistance to chemotherapy: new treatments and novel insights into an old problem
Raguz, S., & Yagüe, E. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604510 · Cited by 312
Papagianni, M. (2003) · Biotechnology Advances · doi:10.1016/s0734-9750(03)00077-6 · Cited by 310
Changes in electric charge and phospholipids composition in human colorectal cancer cells
Dobrzyńska, I., Szachowicz-Petelska, B., Sulkowski, S., & Figaszewski, Z. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3557-3 · Cited by 285
Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC 1
Joo, N. E., Ritchie, K., Kamarajan, P., Miao, D., & Kapila, Y. L. (2012) · Cancer Medicine · doi:10.1002/cam4.35 · Cited by 279
Formation of Amyloid Fibers Triggered by Phosphatidylserine-Containing Membranes
Zhao, H., Tuominen, E. K. J., & Kinnunen, P. K. J. (2004) · Biochemistry · doi:10.1021/bi049002c · Cited by 273
Class II antimicrobial peptides from lactic acid bacteria
Nes, I. F., & Holo, H. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<50::aid-bip50>3.0.co;2-3 · Cited by 268
Maher, S., & McClean, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.012 · Cited by 264
Perlova, O., Gerth, K., Kuhlmann, S., Zhang, Y., & Müller, R. (2009) · Microbial Cell Factories · doi:10.1186/1475-2859-8-1 · Cited by 252
The biology of E colicins: paradigms and paradoxes
James, R., Kleanthous, C., & Moore, G. R. (1996) · Microbiology · doi:10.1099/13500872-142-7-1569 · Cited by 244
Fimland, G., Johnsen, L., Dalhus, B., & Nissen‐Meyer, J. (2005) · Journal of Peptide Science · doi:10.1002/psc.699 · Cited by 227
Kamarajan, P., Hayami, T., Matte, B., Liu, Y., Danciu, T., Ramamoorthy, A., Worden, F., Kapila, S., & Kapila, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131008 · Cited by 214
BOWMAN, C. M., SIDIKARO, J., & NOMURA, M. (1971) · Nature New Biology · doi:10.1038/newbio234133a0 · Cited by 200
Sahl, H. G., Kordel, M., & Benz, R. (1987) · Archives of Microbiology · doi:10.1007/bf00425076 · Cited by 191
Zhao, H., Sood, R., Jutila, A., Bose, S., Fimland, G., Nissen-Meyer, J., & Kinnunen, P. K. J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.037 · Cited by 183
Tomita, K., Ogawa, T., Uozumi, T., Watanabe, K., & Masaki, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140213797 · Cited by 177
Heterologous production of bacteriocins by lactic acid bacteria
Rodríguez, J. (2003) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(02)00153-8 · Cited by 172
Colicins: structures, modes of action, transfer through membranes, and evolution
Braun, V., Pilsl, H., & Gro�, P. (1994) · Archives of Microbiology · doi:10.1007/bf00248693 · Cited by 171
Membrane fluidity characteristics of human lung cancer
Sok, M., Šentjurc, M., & Schara, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00044-0 · Cited by 163
Bacteriocidal activity ofLactobacillus plantarum C-11
Daeschel, M. A., McKenney, M. C., & McDonald, L. C. (1990) · Food Microbiology · doi:10.1016/0740-0020(90)90014-9 · Cited by 161
Hetz, C. A., Bono, M. R., Barros, L. F., & Lagos, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052709699 · Cited by 160
Purification of bacteriocins of lactic acid bacteria: problems and pointers
Carolissen-Mackay, V., Arendse, G., & Hastings, J. W. (1997) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(96)01167-1 · Cited by 151
Paiva, A. D., de Oliveira, M. D., de Paula, S. O., Baracat‐Pereira, M. C., Breukink, E. J., & Mantovani, H. C. (2012) · Microbiology · doi:10.1099/mic.0.062190-0 · Cited by 147
Structure and genetics of circular bacteriocins
van Belkum, M. J., Martin‐Visscher, L. A., & Vederas, J. C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.004 · Cited by 142
Bovicin HC5, a bacteriocin from Streptococcus bovis HC5
Mantovani, H. C., Hu, H., Worobo, R. W., & Russell, J. B. (2002) · Microbiology · doi:10.1099/00221287-148-11-3347 · Cited by 139
Pore-Forming Colicins and Their Relatives
Lakey, J. H., & Slatin, S. L. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-56508-3_7 · Cited by 120
Human tumor cells are selectively inhibited by colicins
Chumchalová, J., & Šmarda, J. (2003) · Folia Microbiologica · doi:10.1007/bf02931286 · Cited by 114
Nissen-Meyer, J., Larsen, A. G., Sletten, K., Daeschel, M. A., & Nes, I. F. (1993) · Journal of General Microbiology · doi:10.1099/00221287-139-9-1973 · Cited by 111
The Circular Bacteriocins Gassericin A and Circularin A
Kawai, Y., Kemperman, R., Kok, J., & Saito, T. (2004) · Current Protein and Peptide Science · doi:10.2174/1389203043379549 · Cited by 107
Immunomodulatory efficacy of nisin—a bacterial lantibiotic peptide
Begde, D. N., Bundale, S., Mashitha, P., Rudra, J., Nashikkar, N., & Upadhyay, A. (2011) · Journal of Peptide Science · doi:10.1002/psc.1341 · Cited by 104
Antibacterial and Antitumorigenic Properties of Microcin E492, a Pore- Forming Bacteriocin
Lagos, R., Tello, M., Mercado, G., Garcia, V., & Monasterio, O. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109787048643 · Cited by 104
Villarante, K. I., Elegado, F. B., Iwatani, S., Zendo, T., Sonomoto, K., & de Guzman, E. E. (2010) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-010-0541-1 · Cited by 103
Isolation and characterization of microcin E 492 fromKlebsiella pneumoniae
de Lorenzo, V. (1984) · Archives of Microbiology · doi:10.1007/bf00692715 · Cited by 102
Development of Class IIa Bacteriocins as Therapeutic Agents
Lohans, C. T., & Vederas, J. C. (2011) · International Journal of Microbiology · doi:10.1155/2012/386410 · Cited by 97
Brader, P., Stritzker, J., Riedl, C. C., ZANZONICO, P. B., Cai, S., Burnazi, E. M., Ghani, E. R., Hricak, H., Szalay, A. A., Fong, Y., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4254 · Cited by 91
de Lorenzo, V., & Pugsley, A. P. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.4.666 · Cited by 88
Antigenic property of pediocin AcH produced by Pediococcus acidilactici H
Bhunia, A. K., Johnson, M. C., Ray, B., & Belden, E. (1990) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1990.tb01511.x · Cited by 80
Structure and dynamics of the colicin E1 channel
Cramer, W. A., Cohen, F., Merrill, A. R., & Song, H. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00619.x · Cited by 80
Antibiotics and probiotics in inflammatory bowel disease
Kruis, W. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02051.x · Cited by 80
Colicins—Exocellular lethal proteins ofEscherichia coli
Šmarda, J., & Šmajs, D. (1998) · Folia Microbiologica · doi:10.1007/bf02816372 · Cited by 79
Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis—a possible adjunct therapy
Preet, S., Bharati, S., Panjeta, A., Tewari, R., & Rishi, P. (2015) · Tumor Biology · doi:10.1007/s13277-015-3571-3 · Cited by 78
Microcin E492 forms ion channels in phospholipid bilayer membranes
Lagos, R., Wilkens, M., Vergara, C., Cecchi, X., & Monasterio, O. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80096-d · Cited by 70
Solution structure of plantaricin C, a novel lantibiotic
Turner, D. L., Brennan, L., Meyer, H. E., Lohaus, C., Siethoff, C., Costa, H. S., Gonzalez, B., Santos, H., & Suárez, J. E. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00674.x · Cited by 66
Ali, A. A., Worobec, E. A., Deezagi, A., & Malekzadeh, F. (2004) · Canadian Journal of Microbiology · doi:10.1139/w04-019 · Cited by 65
Role of Lipid II and Membrane Thickness in the Mechanism of Action of the Lantibiotic Bovicin HC5
Paiva, A. D., Breukink, E. J., & Mantovani, H. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00638-11 · Cited by 64
In Vitro Cytotoxicity of Native and Rec-Pediocin CP2 Against Cancer Cell Lines: A Comparative Study
Kumar, B. (2012) · Pharmaceutica Analytica Acta · doi:10.4172/2153-2435.1000183 · Cited by 52
Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia.
Farkas-Himsley, H., & Cheung, R. (1976) · PubMed · Cited by 49
Sand, S. L., Nissen-Meyer, J., Sand, O., & Haug, T. M. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.11.001 · Cited by 49
Antineoplastic Properties of Bacteriocins
Cornut, G., Fortin, C., & Soulières, D. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31815e456d · Cited by 45
Scanning electron microscopic analysis of breast aspirates
CHAUDHARY, J., & Munshi, M. M. (1995) · Cytopathology · doi:10.1111/j.1365-2303.1995.tb00469.x · Cited by 43
Sand, S. L., Oppegård, C., Ohara, S., Iijima, T., Naderi, S., Blomhoff, H. K., Nissen-Meyer, J., & Sand, O. (2010) · Peptides · doi:10.1016/j.peptides.2010.04.010 · Cited by 42
Synthesis of Trypsin-Resistant Variants of the Listeria -Active Bacteriocin Salivaricin P
O'Shea, E. F., O’Connor, P. M., Cotter, P. D., Ross, R. P., & Hill, C. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.00523-10 · Cited by 42
Sand, S. L., Haug, T. M., Nissen-Meyer, J., & Sand, O. (2007) · The Journal of Membrane Biology · doi:10.1007/s00232-007-9030-3 · Cited by 36
Structure analysis of the two-peptide bacteriocin lactococcin G by introducing d-amino acid residues
Oppegård, C., Rogne, P., Kristiansen, P. E., et al. (2010) · Microbiology · doi:10.1099/mic.0.038430-0 · Cited by 35
Recent updated aspects of colicins of Enterobacteriaceae
Cursino, L., marda, J., Chartone‐Souza, E., et al. (2002) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822002000300001 · Cited by 34
[Bacteriocins produced by lactic acid bacteria].
Bilková, A., Sepová, H. K., Bilka, F., & Balážová, A. (2011) · PubMed · Cited by 33
Effect of colicin E3 on leukemia cells P 388 in vitro
Fuska, J., Fusková, A., Šmarda, J., et al. (1979) · Cellular and Molecular Life Sciences · doi:10.1007/bf01964380 · Cited by 29
In vitro inactivation of ascites ribosomes by colicin E 3
Turnowsky, F., Drews, J., Eich, F., & Högenauer, G. (1973) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(73)90991-1 · Cited by 25
The receptor for colicin E3. Isolation and some properties.
Imajoh, S., Ohno‐Iwashita, Y., & Imahori, K. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)65167-5 · Cited by 24
Cytotoxicity of pyocin S2 to tumor and normal cells and its interaction with cell surfaces
Watanabe, T., & Saito, H. (1980) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(80)90039-2 · Cited by 24
Saito, H., & Watanabe, T. (1979) · PubMed · Cited by 21
The cytotoxic and cytocidal effect of colicin E3 on mammalian tissue cells
Šmarda, J., Obdržálek, V., Taborsky, I., et al. (1978) · Folia Microbiologica · doi:10.1007/bf02876680 · Cited by 21
Cloning and expression of bacteriocins of Pediococcus spp.: A review
Kumar, B., Balgir, P. P., Kaur, B., & Garg, N. (2011) · Archives of Clinical Microbiology · Cited by 20
Cytotoxic Effects of Colicins E1 and E3 on v-myb-Transformed Chicken Monoblasts
Šmarda, J., Fialová, M., & Šmarda, J. (2001) · Folia Biologica · doi:10.14712/fb2001047010011 · Cited by 20
Rich, F. J., Kuhn, S. P., Hyde, E. J., Harper, J. L., Ronchese, F., & Kirman, J. R. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1291-8 · Cited by 18
Surface Glycosaminoglycans Protect Eukaryotic Cells against Membrane-Driven Peptide Bacteriocins
Martín, R., Escobedo, S., Martín, C., Crespo, A., Quirós, L. M., & Suárez, J. E. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04427-14 · Cited by 15
Cited by
Functions and emerging applications of bacteriocins
Chikindas, M. L., Weeks, R., Drider, D., Chistyakov, V. A., & Dicks, L. M. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.07.011 · Cited by 574
Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations
Soltani, S., Hammami, R., Cotter, P. D., Rebuffat, S., Said, L. B., Gaudreau, H., Bédard, F., Biron, E., Drider, D., & Fliss, I. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa039 · Cited by 544
Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview
Vivas, R., Barbosa, A. A. T., Dolabela, S. S., & Jain, S. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0319 · Cited by 343
Meade, E., Slattery, M. A., & Garvey, M. (2020) · Antibiotics · doi:10.3390/antibiotics9010032 · Cited by 320
Gut microbiota as a source of novel antimicrobials
Garcia-Gutierrez, E., Mayer, M. J., Cotter, P. D., & Narbad, A. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1455790 · Cited by 292
Metadata
- Authors
- Kaur, S., & Kaur, S.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2015-11-10
- Volume
- 6
- Pages
- 272-272
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2176673138
- Cited by
- 269
- References
- 86
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.